ORAL ONCOLOGY

Scope & Guideline

Advancing Knowledge in Oral Cancer Research

Introduction

Welcome to the ORAL ONCOLOGY information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of ORAL ONCOLOGY, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN1368-8375
PublisherELSEVIER
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 1996 to 2024
AbbreviationORAL ONCOL / Oral Oncol.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressRADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS

Aims and Scopes

The journal 'Oral Oncology' focuses on advancing the understanding and treatment of oral and oropharyngeal cancers through high-quality research and clinical insights. It aims to provide a platform for the dissemination of knowledge that can enhance patient care and outcomes in the field of head and neck oncology.
  1. Clinical Research in Oral Cancer:
    The journal emphasizes clinical studies that evaluate treatment efficacy, patient outcomes, and novel therapeutic approaches in oral and oropharyngeal cancers.
  2. Molecular and Genomic Insights:
    Research exploring the molecular and genetic underpinnings of head and neck cancers, including studies on biomarkers, tumor microenvironment, and genetic mutations.
  3. Innovative Surgical Techniques:
    Focus on advancements in surgical methodologies, including minimally invasive techniques such as transoral robotic surgery (TORS) and their impacts on patient recovery and outcomes.
  4. Radiation Oncology:
    Studies analyzing the role of radiotherapy, including novel techniques and combinations with immunotherapy, to improve care for head and neck cancer patients.
  5. Quality of Life and Patient-Reported Outcomes:
    Research investigating the psychosocial aspects and quality of life for patients undergoing treatment for head and neck cancers.
  6. Preventive and Screening Strategies:
    Exploration of preventive measures, screening protocols, and early detection strategies to improve outcomes for patients at risk for oral cancers.
  7. Multidisciplinary Approaches:
    Highlighting the importance of collaborative care models that integrate various specialties in the management of head and neck cancers.
Recent publications in 'Oral Oncology' indicate a shift towards several emerging themes that reflect current trends in research and clinical practice. These trends signify the evolving landscape of oral cancer treatment and management.
  1. Immunotherapy and Targeted Treatments:
    An increasing number of studies focus on the role of immunotherapy, particularly involving PD-1/PD-L1 inhibitors and their combinations with other treatment modalities.
  2. Artificial Intelligence in Oncology:
    Emerging research utilizing AI for diagnostic imaging, predictive modeling, and enhancing treatment planning is becoming a prominent theme.
  3. Patient-Centric Outcomes:
    A growing emphasis on patient-reported outcomes and quality of life assessments, reflecting a shift towards holistic patient care.
  4. Genomic Profiling and Biomarkers:
    There is a trend towards identifying genomic markers and their implications for personalized treatment approaches in oral cancers.
  5. Telemedicine and Remote Care:
    The COVID-19 pandemic has accelerated research into telemedicine applications for monitoring and managing patients with head and neck cancers.
  6. Multidisciplinary Care Models:
    An emerging focus on collaborative care approaches that integrate various specialties in the management of complex cases in oral oncology.

Declining or Waning

While 'Oral Oncology' continues to thrive in several areas, some themes are showing a decline in prominence. This may reflect shifts in research focus, funding, or evolving clinical practices.
  1. Traditional Chemotherapy Studies:
    There is a noticeable decrease in publications focusing solely on traditional chemotherapy regimens for oral cancers, as attention shifts towards personalized medicine and targeted therapies.
  2. Basic Science Research:
    A decline in purely laboratory-based studies that do not translate directly to clinical applications, as the journal prioritizes translational research with direct patient implications.
  3. Single-institution Studies:
    Fewer studies from single institutions are being published, as larger, multicenter studies are becoming more favored for their robustness and generalizability.
  4. Non-surgical Treatment Modalities:
    The focus on non-surgical interventions, such as purely palliative care studies, appears to be waning in favor of more aggressive and curative approaches.
  5. Historical Perspectives:
    Less emphasis on historical analyses of treatment outcomes or retrospective studies that do not incorporate modern methodologies or technologies.

Similar Journals

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA

Connecting Researchers and Clinicians for Better Outcomes
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 0889-8588Frequency: 6 issues/year

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, published by W B SAUNDERS CO-ELSEVIER INC, is a premier journal dedicated to advancing the fields of hematology and oncology. With its ISSN 0889-8588 and E-ISSN 1558-1977, this esteemed publication has been a cornerstone of clinical scholarship since its inception in 1987, providing comprehensive annual updates that bridge the gap between research and clinical practice. Known for its rigorous editorial standards and impactful contributions, the journal holds a respectable Q2 quartile classification in both hematology and oncology as of 2023, ranking it in the 50th percentile among its peers. Although it is not an open-access journal, the content is accessible to institutions and professionals worldwide. As the scope of the journal expands through 2024, it continues to attract an audience of researchers, healthcare professionals, and students who seek to stay informed on the latest advancements, treatment modalities, and groundbreaking studies in the fields of hematology and oncology.

Breast Cancer

Transforming insights into impactful breast cancer solutions.
Publisher: SPRINGER JAPAN KKISSN: 1340-6868Frequency: 6 issues/year

Breast Cancer is a prestigious peer-reviewed journal published by SPRINGER JAPAN KK, specializing in the multifaceted domains of oncology and medical pharmacology. With an impressive impact factor and recognized within the Q1 category in multiple areas, including Medicine (miscellaneous), Radiology, and Nuclear Medicine and Imaging, this journal serves as a fundamental resource for cutting-edge research and clinical advancements in breast cancer treatment and care. Its indexed presence in renowned databases like Scopus further affirms its significance, ranking 56th in Radiology and 60th in Pharmacology. The journal aims to bridge the gap between clinical practice and scientific research by publishing original articles, reviews, and case studies that enhance understanding and improve patient outcomes. With converged content available from 1994 to 2024, the journal is dedicated to fostering innovative research while engaging a global audience of researchers, clinicians, and students passionate about tackling breast cancer challenges.

INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY

Unveiling breakthroughs in oral surgery and patient care.
Publisher: CHURCHILL LIVINGSTONEISSN: 0901-5027Frequency: 12 issues/year

INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY is a premier peer-reviewed journal published by Churchill Livingstone, dedicated to advancing the field of oral and maxillofacial surgery. With an impressive Q1 ranking in the categories of Oral Surgery, Otorhinolaryngology, and Surgery as of 2023, this journal serves as a vital resource for researchers, clinicians, and students alike, offering cutting-edge research findings, clinical studies, and innovative surgical techniques. The journal covers a wide range of topics within its scope, ensuring that it remains at the forefront of advancements in surgical practice and patient care. Though it operates under a traditional access model, its Impact Factor reflects its significance in the field and its role in disseminating critical knowledge. Established in 1986, the INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY continues to be an essential tool for those dedicated to enhancing therapeutic outcomes and surgical methodologies, solidifying its position as a trusted resource in the ongoing evolution of maxillofacial sciences.

Clinical Oral Investigations

Uncovering insights that transform dental care.
Publisher: SPRINGER HEIDELBERGISSN: 1432-6981Frequency: 9 issues/year

Clinical Oral Investigations is a premier journal published by SPRINGER HEIDELBERG, specializing in the multifaceted field of dentistry. Established in 1997, this journal serves as an essential resource for researchers, practitioners, and students alike, offering a platform for the dissemination of high-quality peer-reviewed studies that advance the understanding of oral health and its clinical implications. With an impressive impact factor and ranked in the Q1 category for Dentistry, it occupies a distinguished position among the top-tier publications, reflecting its commitment to excellence as evidenced by a Scopus Rank of #14 out of 132 in General Dentistry, placing it in the 89th percentile. While the journal offers a subscription-based model, it continues to make significant contributions to the field through innovative research articles, reviews, and clinical reports. Located in Heidelberg, Germany, Clinical Oral Investigations is a vital resource for those dedicated to the improvement of oral health and dental practices worldwide.

CLINICAL OTOLARYNGOLOGY

Transforming Clinical Practices through Rigorous Research
Publisher: WILEYISSN: 1749-4478Frequency: 6 issues/year

CLINICAL OTOLARYNGOLOGY is a prestigious peer-reviewed journal published by Wiley that focuses on advancing research in the field of otorhinolaryngology, including topics such as laryngeal surgery, sinus diseases, and head and neck oncology. With an ISSN of 1749-4478 and an E-ISSN of 1749-4486, this journal has established itself as a vital resource for healthcare professionals, researchers, and students interested in ear, nose, and throat (ENT) medicine. The journal is recognized for its rigorous standards, exemplified by its Q2 ranking in both the Medicine (Miscellaneous) and Otorhinolaryngology categories, as per the 2023 Scopus ranking, placing it within the 71st percentile among global journals in its field. Operating from its UK base in Hoboken, NJ, CLINICAL OTOLARYNGOLOGY also contributes to the scientific community's understanding of this specialized area of medicine, with a publication timeline spanning from 2005 to 2024. While it does not offer an open-access model, the journal's quality and impact make it a crucial platform for disseminating high-caliber research that informs clinical practices and fosters innovation in otolaryngology.

Molecular and Clinical Oncology

Transforming insights into impactful oncology practices.
Publisher: SPANDIDOS PUBL LTDISSN: 2049-9450Frequency: 12 issues/year

Molecular and Clinical Oncology is a dynamic journal published by SPANDIDOS PUBL LTD, aimed at advancing the understanding of cancer biology and treatment modalities. With an ISSN of 2049-9450 and an E-ISSN of 2049-9469, the journal serves as a critical platform for researchers and clinicians dedicated to uncovering novel insights in molecular oncology and enhancing clinical practices. As a testament to its growing influence, the journal has achieved a Q3 ranking in Oncology and a Q4 ranking in Cancer Research for the year 2023, reflecting its commitment to publishing high-quality research. Although currently not an Open Access publication, the journal offers crucial subscription options, ensuring comprehensive access to groundbreaking studies and innovations in the field. With converged years spanning 2018 to 2024, the journal is set to continue enriching the academic community with its valuable contributions, ultimately empowering researchers, professionals, and students engaged in the fight against cancer.

JOURNAL OF SURGICAL ONCOLOGY

Bridging Surgery and Oncology for Better Outcomes
Publisher: WILEYISSN: 0022-4790Frequency: 16 issues/year

The JOURNAL OF SURGICAL ONCOLOGY, published by Wiley, stands as a pivotal resource for medical professionals, researchers, and students engaged in the fields of surgery and oncology. Established in 1969, this esteemed journal covers a diverse range of topics related to the surgical management of cancer, supporting advancements in treatment protocols and patient care. With a Q1 ranking in Surgery and Q2 rankings in both Medicine and Oncology for 2023, it holds a prominent position in the academic landscape, underscoring its impact in enhancing surgical techniques and oncological research. Researchers looking to disseminate their findings will benefit from the journal's rigorous peer-review process and commitment to publishing high-quality content that drives innovation in the field. For access, readers will find both print and online formats available, making vital research accessible to a broad audience committed to improving surgical oncology practice.

Indian Journal of Surgical Oncology

Fostering Innovation in Surgical Techniques
Publisher: SPRINGER INDIAISSN: 0975-7651Frequency: 4 issues/year

The Indian Journal of Surgical Oncology, published by SPRINGER INDIA, is a vital source of scholarly research and discourse in the fields of oncology and surgery. Since its inception in 2010, the journal has been dedicated to advancing the science and practice of surgical oncology, providing a platform for researchers, clinicians, and educators to disseminate their findings and insights. With an increasing impact factor, the journal currently ranks in the Q4 category in Oncology and Q3 category in Surgery, reflecting its growing influence in the academic community. The journal maintains a focus on high-quality research, clinical studies, and innovative surgical techniques, fostering knowledge exchange among professionals in India and beyond. Although an open access option is not provided, the journal remains an essential repository of information for anyone engaged in the rapidly evolving fields of surgical oncology. For access to groundbreaking research and updates in the discipline, the Indian Journal of Surgical Oncology continues to be an indispensable resource.

SEMINARS IN RADIATION ONCOLOGY

Shaping Tomorrow's Cancer Treatments Today
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 1053-4296Frequency: 4 issues/year

SEMINARS IN RADIATION ONCOLOGY is a premier journal published by W B SAUNDERS CO-ELSEVIER INC, dedicated to advancing the field of radiation oncology through high-quality research and comprehensive reviews. With an impressive impact factor and a notable HIndex, this journal holds a prominent place within the academic community, particularly illustrated by its Q2 ranking in both Cancer Research and Oncology, and a Q1 ranking in Radiology, Nuclear Medicine, and Imaging as of 2023. Since its inception in 1991, the journal has served as a vital resource for researchers, clinicians, and healthcare professionals, facilitating the exchange of innovative ideas and practices that shape the future of cancer treatment. While the journal is not open access, it offers essential insights into the latest advancements in the field, catering to a diverse audience eager to expand their knowledge and improve patient outcomes in the realm of radiation therapy.

World Journal of Surgical Oncology

Elevating standards in oncology surgery with impactful findings.
Publisher: BMCISSN: Frequency: 1 issue/year

The World Journal of Surgical Oncology, published by BMC, is a leading open-access journal that has been disseminating high-quality research since 2003. With an impressive impact, it currently holds a Q2 ranking in Oncology and a Q1 ranking in Surgery for the year 2023, reflecting its significant contribution to the field. Based in the United Kingdom, this journal serves as a vital platform for researchers, clinicians, and students alike, offering comprehensive coverage on topics ranging from innovative surgical techniques to oncology treatment advancements. As part of the esteemed BMC portfolio, the journal leverages a robust editorial process to ensure the publication of impactful research articles that promote a deeper understanding and enhancement of surgical oncology practices. Its commitment to open access ensures that critical research findings are widely accessible, fostering collaboration and knowledge sharing within the global medical community. For those dedicated to advancing their expertise in surgical oncology, the World Journal of Surgical Oncology is an indispensable resource that reflects the forefront of research and clinical practice.